Wall Street Zen upgraded shares of Senseonics (NASDAQ:SENS – Free Report) from a sell rating to a hold rating in a research report released on Saturday morning,Wall Street Zen reports.
A number of other research firms have also recently issued reports on SENS. TD Cowen boosted their price objective on Senseonics from $15.00 to $17.00 and gave the company a “buy” rating in a report on Tuesday, November 10th. HC Wainwright reiterated a “buy” rating and issued a $14.00 target price on shares of Senseonics in a research note on Tuesday, November 10th. Mizuho lifted their target price on Senseonics from $18.00 to $20.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 10th. Raymond James Financial raised shares of Senseonics from an “underperform” rating to a “market perform” rating in a research note on Tuesday, November 10th. Finally, Weiss Ratings upgraded shares of Senseonics from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, November 4th. Three analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $14.40.
Check Out Our Latest Stock Report on SENS
Senseonics Trading Up 5.4%
SENS traded up $0.54 during trading on Friday, reaching $10.58. The company had a trading volume of 1,118,857 shares, compared to its average volume of 912,810. The company has a quick ratio of 6.40, a current ratio of 5.92 and a debt-to-equity ratio of 0.70. The business has a 50 day simple moving average of $9.17 and a 200-day simple moving average of $7.33. The stock has a market cap of $442.24 million, a P/E ratio of -4.60 and a beta of 1.04. Senseonics has a 52 week low of $4.79 and a 52 week high of $13.98.
Senseonics (NASDAQ:SENS – Get Free Report) last posted its quarterly earnings data on Monday, November 9th. The company reported ($0.50) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.49) by ($0.01). Senseonics had a negative net margin of 204.01% and a negative return on equity of 186.11%. The firm had revenue of $19.56 million for the quarter. On average, equities analysts anticipate that Senseonics will post -2.20 EPS for the current fiscal year.
Insider Buying and Selling at Senseonics
In other news, Director Douglas Roeder acquired 13,953 shares of the firm’s stock in a transaction that occurred on Wednesday, August 19th. The stock was purchased at an average cost of $8.98 per share, for a total transaction of $125,297.94. Following the completion of the acquisition, the director directly owned 171,191 shares of the company’s stock, valued at $1,537,295.18. The trade was a 8.87% increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. 4.70% of the stock is owned by insiders.
Hedge Funds Weigh In On Senseonics
Several institutional investors have recently bought and sold shares of the business. BlackRock Inc. purchased a new position in shares of Senseonics in the 2nd quarter worth approximately $15,867,000. Masters Capital Management LLC increased its holdings in shares of Senseonics by 100.0% during the first quarter. Masters Capital Management LLC now owns 500,000 shares of the company’s stock valued at $3,330,000 after acquiring an additional 250,002 shares in the last quarter. Bank of America Corp DE purchased a new position in shares of Senseonics in the 2nd quarter valued at approximately $2,241,000. Empowered Funds LLC acquired a new stake in Senseonics in the 3rd quarter worth approximately $621,000. Finally, Readystate Asset Management LP acquired a new stake in Senseonics in the 2nd quarter worth approximately $574,000. 12.36% of the stock is owned by hedge funds and other institutional investors.
Latest Senseonics News
Investors following SENS have been watching these news items:
- Positive Sentiment: Mizuho and Barclays issued forecasts pointing to potential price appreciation, and TD Cowen raised its price target. These positive calls may bolster investor confidence. Mizuho forecast Barclays forecast TD Cowen price-target update
- Neutral Sentiment: Stifel Nicolaus assigned a Hold rating, while Raymond James upgraded SENS to Market Perform. These stances are more cautious than a Buy recommendation but do not signal an outright bearish view. Stifel rating Raymond James rating
- Negative Sentiment: HC Wainwright lowered several 2026–2027 quarterly EPS forecasts and its FY2027 estimate, reflecting expectations of larger losses in those periods. This tempers the positive longer-term revisions. HC Wainwright earnings estimate revisions
Senseonics Company Profile
Senseonics Holdings, Inc. develops continuous glucose monitoring (CGM) technology for people with diabetes. Its Eversense systems use a small sensor implanted under the skin to measure glucose levels, an external wearable transmitter to send readings, and a mobile app to display data and provide alerts. The company’s product line includes implantable CGM systems designed for extended wear, including the Eversense 365 system, which is designed to last up to one year. Unlike many CGM products that use sensors replaced more frequently, Eversense sensors are inserted and removed by a healthcare professional.
Further Reading
- Five stocks we like better than Senseonics
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.
